drugset / Trial / NCT01561404

Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise

NCT01561404

Phase 4 Terminated 3 enrolled Josep m Cruzado
NaSingle-groupOpen-labelBasic science

Summary

This is an exploratory study based on the hypothesis that kidney transplant patients treated with an immunosuppressive therapy based on an inhibitor of the mammalian target of rapamycin (m-TOR) may increase resistance to physical exercise, which would result in an improvement in the quality of life of these patients.

Timeline

Start
2011-09
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule